| Astral Resources NL (AAR) ORDINARY FULLY PAID |
Materials |
$324 |
Group Mineral Resource Increases to 1.62 Million Ounces
|
3 Apr 2025 9:01AM |
$0.165 |
$0.180 |
risen by
9.09%
|
|
AAR - Price-sensitive ASX Announcement
Full Release
Key Points
- Group Mineral Resource increases to 1.62 million ounces.
- Indicated Resources at Mandilla exceed one million ounces.
- 49% increase in Indicated Resources supports upcoming Pre-Feasibility Study.
- Mandilla MRE estimated at 42Mt at 1.1g/t Au for 1.43Moz of contained gold.
- Success in infill drilling delivers significant increases in higher confidence resources.
- Discovery cost for additional ounces recorded at approximately $26 per ounce.
- Theia deposit now hosts 1.15Moz, with 72% of ounces in the higher confidence Indicated category.
- Ongoing exploration programs at Feysville and other deposits are expected to enhance resource estimates.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EQT Holdings Limited (EQT) ORDINARY FULLY PAID |
Financials |
$536 |
Investor Briefing Presentation
|
3 Apr 2025 9:01AM |
$33.000 |
$20.010 |
fallen by
39.36%
|
|
EQT - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong growth in Responsible Entity / Trustee services.
- 47 new funds established YTD with 26 in implementation.
- 30% revenue growth on PCP in Custody and DSS business segments.
- Material growth in platform funds.
- Trustee for Perpetual Funds commenced 1 March 2025.
- Revenue growth through regulatory change for FY25.
- Growth opportunities in pipeline for FY26.
- Independent model increasingly favored by market.
- Enduring, long-term recurring revenue with indexation to market for high proportion of fees.
- Positive outlook with earnings growth expected for FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IPH Limited (IPH) ORDINARY FULLY PAID |
Industrials |
$861 |
Update - Notification of buy-back - IPH
|
3 Apr 2025 9:01AM |
$4.520 |
$3.290 |
fallen by
27.21%
|
|
| PRO-PAC Packaging Limited (PPG) ORDINARY FULLY PAID |
Materials |
$3 |
Becoming a substantial holder
|
3 Apr 2025 9:00AM |
$0.023 |
$0.018 |
fallen by
21.74%
|
|
| Riversgold Limited (RGL) ORDINARY FULLY PAID |
Materials |
$28 |
Gold Results Continue to Shine at Kalgoorlie East Project
|
3 Apr 2025 8:59AM |
$0.004 |
$0.012 |
risen by
200%
|
|
RGL - Price-sensitive ASX Announcement
Full Release
Key Points
- Further 1,756 samples are awaiting assay.
- Results confirm high-grade gold intercepts within a lower grade gold halo.
- Significant shallow gold intercepts recorded from five drill holes.
- Total of 36 drill holes for 1,756 samples submitted for assay.
- Drilling continues to probe the porphyry over an increasing footprint.
- Dynamic Leapfrog gold model for Northern Zone will be updated.
- Possible ore processing scenarios demonstrated by recent successful projects nearby.
- Company aims for a sizeable low-grade heap leach operation similar to other successful projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Thorney Opportunities Ltd (TOP) ORDINARY FULLY PAID |
Financials |
$91 |
Update - Notification of buy-back - TOP
|
3 Apr 2025 8:57AM |
$0.595 |
$0.540 |
fallen by
9.24%
|
|
| Iceni Gold Limited (ICL) ORDINARY FULLY PAID |
Materials |
$13 |
Diamond Drilling Underway at Everleigh Deeps
|
3 Apr 2025 8:57AM |
$0.065 |
$0.032 |
fallen by
50.77%
|
|
| Big River Industries Limited (BRI) ORDINARY FULLY PAID |
Materials |
$131 |
Application for quotation of securities - BRI
|
3 Apr 2025 8:57AM |
$1.275 |
$1.395 |
risen by
9.41%
|
|
| PRO-PAC Packaging Limited (PPG) ORDINARY FULLY PAID |
Materials |
$3 |
Becoming a substantial holder
|
3 Apr 2025 8:57AM |
$0.023 |
$0.018 |
fallen by
21.74%
|
|
| Racura Oncology Ltd (RAC) ORDINARY FULLY PAID |
Health Care |
$478 |
RC220 Phase 1 Trial Opens for Patient Enrolment
|
3 Apr 2025 8:57AM |
$1.145 |
$2.630 |
risen by
129.69%
|
|
RAC - Price-sensitive ASX Announcement
Full Release
Key Points
- RC220 Phase 1 trial opens at Southside Cancer Care Centre.
- Trial aims to assess safety and pharmacokinetics of RC220 with doxorubicin.
- Initial enrollment of up to 33 patients with further assessments planned.
- Trial will provide data on cardioprotective properties and anticancer efficacy.
- Conducted across multiple sites in Australia, Hong Kong, and South Korea.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Barton Gold Holdings Limited (BGD) ORDINARY FULLY PAID |
Materials |
$208 |
Application for quotation of securities - BGD
|
3 Apr 2025 8:57AM |
$0.400 |
$0.870 |
risen by
117.50%
|
|
| Aspire Mining Limited (AKM) ORDINARY FULLY PAID |
Materials |
$119 |
Aspire Enters MoU on Trailer Design, Supply and Maintenance
|
3 Apr 2025 8:56AM |
$0.290 |
$0.235 |
fallen by
18.97%
|
|
| Navigator Global Investments Limited (NGI) FPO-U.S. INVESTOR PROHIBITED EXCEPT QPS |
Financials |
$1,007 |
Goldman Sachs Emerging Leaders Conference Presentation
|
3 Apr 2025 8:56AM |
$1.870 |
$2.050 |
risen by
9.63%
|
|
| Newmont Corporation (NEM) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$173,355 |
Statement of CDIs on issue - NEM
|
3 Apr 2025 8:56AM |
$76.310 |
$159.330 |
risen by
108.79%
|
|
| xReality Group Ltd (XRG) ORDINARY FULLY PAID |
Consumer Discretionary |
$40 |
Strategic law enforcement research program
|
3 Apr 2025 8:55AM |
$0.034 |
$0.053 |
risen by
55.88%
|
|
XRG - Price-sensitive ASX Announcement
Full Release
Key Points
- Strategic research program established with ALERRT Centre at Texas State University.
- Focus on enhancing active shooter response training using XR technology.
- Initial two-year collaboration with potential for renewal based on mutual agreement.
- Research will optimize Operator XR's technology platform in high-stress law enforcement scenarios.
- ALERRT has trained over 300,000 first responders in the US.
- The collaboration aims to improve human performance in high-stress situations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,510 |
Change of Director's Interest Notice - RL
|
3 Apr 2025 8:54AM |
$2.860 |
$3.960 |
risen by
38.46%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,510 |
Change of Director's Interest Notice - ML
|
3 Apr 2025 8:54AM |
$2.860 |
$3.960 |
risen by
38.46%
|
|
| Resimac Group Limited (RMC) ORDINARY FULLY PAID |
Financials |
$354 |
Update - Notification of buy-back - RMC
|
3 Apr 2025 8:51AM |
$0.855 |
$0.895 |
risen by
4.68%
|
|
| Summerset Group Holdings Limited (SNZ) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$1,809 |
Ongoing Disclosure Notices
|
3 Apr 2025 8:51AM |
$10.190 |
$7.410 |
fallen by
27.28%
|
|
| EROAD Limited (ERD) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Information Technology |
$139 |
Ongoing Disclosure Notice - John Scott
|
3 Apr 2025 8:51AM |
$0.850 |
$0.740 |
fallen by
12.94%
|
|
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$52 |
1st dose level cleared IV combination arm onCARlytics trial
|
3 Apr 2025 8:51AM |
$0.030 |
$0.145 |
risen by
383.33%
|
|
| Argent Biopharma Limited (RGT) ORDINARY FULLY PAID |
Health Care |
$3 |
CannEpil Receives Approval for Prescription in Germany
|
3 Apr 2025 8:49AM |
$0.130 |
$0.038 |
fallen by
70.77%
|
|
RGT - Price-sensitive ASX Announcement
Full Release
Key Points
- CannEpil™ has been approved for prescription in Germany.
- This approval expands Argent BioPharma's presence in the European market.
- Physicians can now prescribe CannEpil™, allowing eligible patients access.
- Approximately 816,000 people in Germany are diagnosed with epilepsy.
- CannEpil™ offers a vital alternative for patients with limited treatment options.
- The approval represents a significant step in the company's European expansion strategy.
- Argent BioPharma aims to provide innovative treatments for CNS disorders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tasmea Limited (TEA) ORDINARY FULLY PAID |
Industrials |
$1,195 |
Acquisition of Flanco Group - Presentation
|
3 Apr 2025 8:48AM |
$2.550 |
$4.590 |
risen by
80%
|
|
TEA - Price-sensitive ASX Announcement
Full Release
Key Points
- Acquisition estimated at approximately A$27 million.
- Flanco Group specializes in civil services and maintenance solutions.
- Transaction expected to enhance Tasmea's operational footprint in the Goldfields region.
- Deal projected to be earnings accretive, enhancing shareholder value.
- Expected completion of the transaction by early May 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tasmea Limited (TEA) ORDINARY FULLY PAID |
Industrials |
$1,195 |
Acquisition of Flanco Group - Announcement
|
3 Apr 2025 8:47AM |
$2.550 |
$4.590 |
risen by
80%
|
|
TEA - Price-sensitive ASX Announcement
Full Release
Key Points
- Tasmea to acquire Flanco Pty Ltd and Flanco Kalgoorlie Pty Ltd.
- Completion of the acquisition expected in early May 2025.
- Flanco Group specializes in civil services and maintenance solutions.
- Flanco Group has achieved strong revenue growth with a CAGR of approximately 23%.
- The acquisition enhances Tasmea's operational capabilities.
- Total consideration of around A$50 million.
- Deal includes upfront cash payment and potential earn-out based on performance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Evolution Mining Limited (EVN) ORDINARY FULLY PAID |
Materials |
$26,439 |
Mungari Expansion Project Commences Commissioning
|
3 Apr 2025 8:46AM |
$7.110 |
$13.020 |
risen by
83.12%
|
|
Call 1300 880 160
Start a chat
Schedule a call
